106 related articles for article (PubMed ID: 10698444)
1. Chemical synthesis and cytotoxicity of some azinomycin analogues devoid of the 1-azabicyclo[3.1.0]hexane subunit.
Hodgkinson TJ; Kelland LR; Shipman M; Suzenet F
Bioorg Med Chem Lett; 2000 Feb; 10(3):239-41. PubMed ID: 10698444
[TBL] [Abstract][Full Text] [Related]
2. Role of the azinomycin naphthoate and central amide in sequence-dependent DNA alkylation and cytotoxicity of epoxide-bearing substructures.
Coleman RS; Burk CH; Navarro A; Brueggemeier RW; Diaz-Cruz ES
Org Lett; 2002 Oct; 4(20):3545-8. PubMed ID: 12323065
[TBL] [Abstract][Full Text] [Related]
3. Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking.
LePla RC; Landreau CA; Shipman M; Hartley JA; Jones GD
Bioorg Med Chem Lett; 2005 Jun; 15(11):2861-4. PubMed ID: 15911269
[TBL] [Abstract][Full Text] [Related]
4. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
[TBL] [Abstract][Full Text] [Related]
5. Mode of action and biosynthesis of the azabicycle-containing natural products azinomycin and ficellomycin.
Foulke-Abel J; Agbo H; Zhang H; Mori S; Watanabe CM
Nat Prod Rep; 2011 Apr; 28(4):693-704. PubMed ID: 21327255
[TBL] [Abstract][Full Text] [Related]
6. Azinomycins A and B, new antitumor antibiotics. II. Chemical structures.
Yokoi K; Nagaoka K; Nakashima T
Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4554-61. PubMed ID: 3829181
[No Abstract] [Full Text] [Related]
7. Design and synthesis of a DNA-crosslinking azinomycin analogue.
Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
[TBL] [Abstract][Full Text] [Related]
8. One-pot synthesis and biological evaluation of aspergillamides and analogues.
Beck B; Hess S; Dömling A
Bioorg Med Chem Lett; 2000 Aug; 10(15):1701-5. PubMed ID: 10937728
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
10. DNA binding and alkylation by the "left half" of azinomycin B.
Zang H; Gates KS
Biochemistry; 2000 Dec; 39(48):14968-75. PubMed ID: 11101313
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of a salicylihalamide A analogue.
Tang S; Erickson KL
J Nat Prod; 2008 May; 71(5):898-901. PubMed ID: 18407694
[TBL] [Abstract][Full Text] [Related]
12. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
13. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.
Siwy M; Sek D; Kaczmarczyk B; Jaroszewicz I; Nasulewicz A; Pelczyñska M; Nevozhay D; Opolski A
J Med Chem; 2006 Jan; 49(2):806-10. PubMed ID: 16420065
[TBL] [Abstract][Full Text] [Related]
15. The Fate of Molecular Oxygen in Azinomycin Biosynthesis.
Kelly GT; Washburn LA; Watanabe CMH
J Org Chem; 2019 Mar; 84(5):2991-2996. PubMed ID: 30680995
[TBL] [Abstract][Full Text] [Related]
16. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
17. Aminoacetone as the penultimate precursor to the antitumor agent azinomycin A.
Sharma V; Kelly GT; Foulke-Abel J; Watanabe CM
Org Lett; 2009 Sep; 11(17):4006-9. PubMed ID: 19663419
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue.
Balan D; Burns CJ; Fisk NG; Hügel H; Huang DC; Segal D; White C; Wagler J; Rizzacasa MA
Org Biomol Chem; 2012 Oct; 10(40):8147-53. PubMed ID: 22964776
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of bicyclic sigma receptor ligands with cytotoxic activity.
Geiger C; Zelenka C; Weigl M; Fröhlich R; Wibbeling B; Lehmkuhl K; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
J Med Chem; 2007 Nov; 50(24):6144-53. PubMed ID: 17967001
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidinones--a new class of anti-staphylococcal antibiotics.
Brands M; Endermann R; Gahlmann R; Krüger J; Raddatz S
Bioorg Med Chem Lett; 2003 Jan; 13(2):241-5. PubMed ID: 12482431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
